FREQ
Closed
Frequency Therapeutics Inc
0.2996
+0.0168 (+5.94%)
Last Update: 03 Nov 2023 23:00:00
Yesterday: 0.2828
Day's Range: 0.2801 - 0.32
Send
sign up or login to leave a comment!
When Written:
0.503
Frequency Therapeutics Inc is a biotechnology company that is focused on developing regenerative medicines to restore hearing loss. The company is based in Woburn, Massachusetts and was founded in 2015 by a team of experts in the fields of regenerative medicine, neuroscience, and inner ear biology. Frequency Therapeutics is developing a first-in-class drug candidate, FX-322, that aims to regenerate sensory hair cells in the inner ear, which are responsible for hearing. The drug is currently in clinical trials and has shown promising results in restoring hearing in patients with sensorineural hearing loss. The company has also developed a platform technology, Progenitor Cell Activation (PCA), which has the potential to regenerate a variety of tissues and organs in the body. Frequency Therapeutics is backed by leading healthcare investors and has partnerships with academic institutions and pharmaceutical companies.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








